Oncology PracticePembrolizumab plus SBRT shows promise for advanced solid tumorsJanuary 27, 2018Immuno-oncologyBreast CancerLung CancerGenitourinary CancerGastroenterologyHead & Neck/Thyroid CancersGynecologic Cancer
Oncology PracticeExperimental PD-1/PARP inhibitor combo shows promise in solid tumorsJanuary 26, 2018Gynecologic CancerImmuno-oncology
Oncology PracticeCombination immunotherapy is active in dMMR/MSI-H metastatic colorectal cancerJanuary 26, 2018Immuno-oncologyGastroenterologyImmunotherapyGastrointestinal Cancer
Oncology PracticeCheckpoint inhibitors look safe in rheumatology patientsJanuary 24, 2018Immuno-oncologyCellular TherapyAggressive Lymphomas
Oncology PracticeImmune-modified RECIST can help identify survival benefit from cancer immunotherapyJanuary 18, 2018Immuno-oncologyLung Cancer
Hematology NewsCRB-410 update: Multiple myeloma response rates remain high with bb2121 CAR T-cell therapyDecember 15, 2017Multiple MyelomaImmuno-oncology
Hematology NewsVIDEO - New lymphoma drug approvals: Clinical use, future directionsDecember 14, 2017Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma
Oncology PracticePANACEA: pembrolizumab overcomes trastuzumab resistance for someDecember 11, 2017Breast CancerImmuno-oncology
Hematology NewsVIDEO: CAR T cell axi-cel drives B-cell lymphomas into remissionDecember 11, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular LymphomaB Cell Lymphoma
Hematology NewsThree-month response to CAR T-cells looks durable in DLBCLDecember 11, 2017Transfusion MedicineAggressive LymphomasImmuno-oncologyLymphoma & Plasma Cell Disorders
Hematology NewsUpdated ZUMA-1 data show durable CAR-T responses in B-cell lymphomasDecember 10, 2017Aggressive LymphomasCellular TherapyIndolent LymphomaLymphoma & Plasma Cell DisordersImmunotherapyImmuno-oncologyFollicular Lymphoma
Oncology PracticeDNA vaccine + PD-1 blockade shows promise in mCRPCDecember 9, 2017Immuno-oncologyImmunotherapyGenitourinary Cancer
Oncology PracticeVIDEO: Dr. Sherene Loi discusses PANACEA trial and implications for pembrolizumab useDecember 7, 2017Breast CancerImmuno-oncology
Oncology PracticeFirst-in-class glutaminase inhibitor combats anti-PD-1/PD-L1 resistanceDecember 2, 2017Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
Oncology PracticeENCORE 601 study: Entinostat shows promise in NSCLCDecember 1, 2017Lung CancerImmuno-oncology
